Sapient Capital LLC Purchases Shares of 18,413 CVS Health Co. (NYSE:CVS)

Sapient Capital LLC purchased a new position in CVS Health Co. (NYSE:CVS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 18,413 shares of the pharmacy operator's stock, valued at approximately $1,454,000.

A number of other institutional investors have also added to or reduced their stakes in the company. Atticus Wealth Management LLC raised its stake in CVS Health by 149.0% during the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator's stock valued at $29,000 after buying an additional 219 shares during the last quarter. Cornerstone Planning Group LLC lifted its stake in shares of CVS Health by 111.5% in the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator's stock worth $32,000 after buying an additional 243 shares in the last quarter. ZRC Wealth Management LLC grew its holdings in shares of CVS Health by 400.0% during the fourth quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator's stock valued at $39,000 after buying an additional 400 shares during the last quarter. Coston McIsaac & Partners raised its holdings in CVS Health by 42.6% in the 4th quarter. Coston McIsaac & Partners now owns 539 shares of the pharmacy operator's stock worth $42,000 after acquiring an additional 161 shares during the last quarter. Finally, Tennessee Valley Asset Management Partners bought a new position in CVS Health in the 4th quarter valued at approximately $50,000. Institutional investors own 80.66% of the company's stock.

Insider Buying and Selling at CVS Health

In related news, Director Edward J. Ludwig bought 1,000 shares of the company's stock in a transaction that occurred on Thursday, May 2nd. The stock was purchased at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the transaction, the director now owns 21,630 shares in the company, valued at $1,165,424.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other news, EVP Prem S. Shah sold 29,473 shares of the company's stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the sale, the executive vice president now directly owns 39,765 shares of the company's stock, valued at approximately $3,059,916.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Edward J. Ludwig bought 1,000 shares of the business's stock in a transaction that occurred on Thursday, May 2nd. The stock was acquired at an average cost of $53.88 per share, with a total value of $53,880.00. Following the completion of the acquisition, the director now owns 21,630 shares of the company's stock, valued at approximately $1,165,424.40. The disclosure for this purchase can be found here. Insiders own 0.24% of the company's stock.

CVS Health Price Performance

NYSE:CVS traded up $0.75 during trading hours on Friday, hitting $55.90. 23,946,075 shares of the stock traded hands, compared to its average volume of 12,498,538. The company has a market cap of $70.18 billion, a price-to-earnings ratio of 9.82, a price-to-earnings-growth ratio of 0.86 and a beta of 0.56. CVS Health Co. has a 1 year low of $53.70 and a 1 year high of $83.25. The stock has a 50 day moving average price of $72.77 and a 200 day moving average price of $73.26. The company has a quick ratio of 0.63, a current ratio of 0.81 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.69 by ($0.38). CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The business had revenue of $88.44 billion during the quarter, compared to analysts' expectations of $89.33 billion. During the same quarter in the previous year, the company posted $2.20 EPS. The company's quarterly revenue was up 3.7% on a year-over-year basis. Sell-side analysts forecast that CVS Health Co. will post 7.03 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd were paid a $0.665 dividend. The ex-dividend date of this dividend was Friday, April 19th. This represents a $2.66 annualized dividend and a yield of 4.76%. CVS Health's payout ratio is 46.75%.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on CVS shares. Wells Fargo & Company lowered their price target on CVS Health from $83.00 to $76.00 and set an "equal weight" rating on the stock in a report on Monday, April 8th. Piper Sandler raised their price target on shares of CVS Health from $93.00 to $94.00 and gave the company an "overweight" rating in a report on Friday, March 15th. SVB Leerink restated a "market perform" rating and set a $60.00 price objective (down previously from $87.00) on shares of CVS Health in a research report on Wednesday. Leerink Partnrs downgraded shares of CVS Health from an "outperform" rating to a "market perform" rating in a research report on Wednesday. Finally, Cantor Fitzgerald cut CVS Health from an "overweight" rating to a "neutral" rating and lowered their price target for the company from $87.00 to $58.00 in a report on Wednesday. Eight research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $80.35.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.